Pharmacokinetic study of voriconazole administered orally at 50 mg/kg in nursehound sharks (Scyliorhinus stellaris) and udulate skates (Raja undulata)

dc.contributor.authorCañizares-Cooz, Daniela
dc.contributor.authorGarcía-Párraga, Daniel
dc.contributor.authorÁlvaro-Álvarez, Teresa
dc.contributor.authorRubio Langre, Sonia
dc.contributor.authorEncinas Cerezo, María Teresa
dc.contributor.authorMorón Elorza, Pablo
dc.date.accessioned2025-08-26T11:17:58Z
dc.date.available2025-08-26T11:17:58Z
dc.date.issued2025
dc.descriptionAuthor contributions: Redaction of the main manuscript was carried out by D.C.C.; review and edition of manuscript D.C.C., P.M.E. and T.E.C.; conceptualization, methodology, and formal analysis was carried out by D.C.C.; P.M.E. and T.E.C., sample collection and processing was carried out by D.C.C., P.M.E., T.E.C., S.R.L. and T.A.A.; project administration and funding acquisition, D.G.P., P.M.E. and T.E.C
dc.description.abstractBackground: Fungal diseases represent an ongoing problem for elasmobranchs kept under human care worldwide. When present, mycoses often lead to high mortality rates, compromising welfare and conservation programs in aquariums. Various fungal species have been identified as causative agents, with Fusarium solani complex most frequently being isolated. Treatment remains unclear; however, recent clinical reports have shown positive outcomes after the administration of azole antifungal drugs to elasmobranchs affected by different fungal infections, specifically for voriconazole. Clinical cases report different dose regimens and administration routes, and pharmacokinetic (PK) studies in elasmobranchs are needed. For this purpose, a PK study was performed and voriconazole was administered at 50 mg/kg PO to six nursehound sharks (Scyliorhinus stellaris) and six undulate skates (Raja undulata). Plasma concentrations were determined using a validated high-performance liquid chromatography (HPLC) method, and PK parameters were estimated using a non-compartmental model. Results: The mean peak plasma concentration (Cmax) ± standard error of the mean (SEM) after oral administration of 50 mg/kg of voriconazole was 3.32 ± 0.92 µg/ml in nursehound sharks and 10.53 ± 0.91 µg/ml in undulate skates. Terminal-half lives for sharks and skates resulted 113.43 ± 29.45 h and 9.88 ± 1.33 h, respectively. Plasma concentrations were above MIC50 in vitro values for Fusarium solani for 54 to 72 h. Conclusions: These findings suggest that voriconazole persists longer in sharks due to extended half-life, whereas in skates, the drug reaches higher plasma concentrations but is eliminated more rapidly. These interspecies variations should be considered when selecting the oral administration route for treatment and determining the appropriate posology regimens for antifungal therapy in elasmobranchs
dc.description.departmentDepto. de Farmacología y Toxicología
dc.description.facultyFac. de Veterinaria
dc.description.refereedTRUE
dc.description.sponsorshipFundación Oceanogràfic
dc.description.statuspub
dc.identifier.citationCañizares-Cooz, D., García-Párraga, D., Álvaro-Álvarez, T., Rubio-Langre, S., Encinas, T., & Morón-Elorza, P. (2025). Pharmacokinetic study of voriconazole administered orally at 50 mg/kg in nursehound sharks (Scyliorhinus stellaris) and udulate skates (Raja undulata). BMC Veterinary Research, 21(1). https://doi.org/10.1186/S12917-025-04930-6
dc.identifier.doi10.1186/s12917-025-04930-6
dc.identifier.essn1746-6148
dc.identifier.officialurlhttps://doi.org/10.1186/S12917-025-04930-6
dc.identifier.pmid40702510
dc.identifier.urihttps://hdl.handle.net/20.500.14352/123409
dc.issue.number484
dc.journal.titleBMC Veterinary Research
dc.language.isoeng
dc.page.final11
dc.page.initial1
dc.publisherBioMed Central
dc.relation.projectIDOCE-22-19 and under the project “Artículo 83/ UCM: Farmacocinética de especies acuáticas”
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.cdu591.9(26)
dc.subject.cdu636.09:615
dc.subject.keywordAdministration
dc.subject.keywordOral
dc.subject.keywordAnimals
dc.subject.keywordAntifungal Agents
dc.subject.keywordFemale
dc.subject.keywordHalf-Life
dc.subject.keywordMale
dc.subject.keywordSharks
dc.subject.keywordSkates
dc.subject.keywordVoriconazole
dc.subject.ucmFarmacología veterinaria
dc.subject.ucmPeces
dc.subject.unesco2401.19 Zoología Marina
dc.subject.unesco3109.08 Farmacología
dc.titlePharmacokinetic study of voriconazole administered orally at 50 mg/kg in nursehound sharks (Scyliorhinus stellaris) and udulate skates (Raja undulata)
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number21
dspace.entity.typePublication
relation.isAuthorOfPublicatione7470fe4-3dc5-4906-9268-64fad1e71642
relation.isAuthorOfPublication9c3c3121-5e9a-4dbd-aac4-a579818572d5
relation.isAuthorOfPublicationd13ab3d4-1a45-4eab-bd34-972cee98b310
relation.isAuthorOfPublication.latestForDiscoverye7470fe4-3dc5-4906-9268-64fad1e71642

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Pharmacokinetic study.pdf
Size:
1.36 MB
Format:
Adobe Portable Document Format

Collections